Under the lights of ASH 2023, the microphone poised to capture insights, Dr. Lorenzo Falchi,…

At ASH 2023, Ola Landgren, MD, Professor of Medicine and Chief Division of Myeloma at…

In a discussion on cancer science, Wassim Mchayleh, MD, explores the role of Minimal Residual…

Rabi Hanna, MD, from the Department of Pediatric Hematology Oncology and BMT at Cleveland Clinic…

At ASH 2023, Hamza Hashmi, MD, a medical doctor and hematologist from Charleston, South Carolina,…

Zandra Klippel, MD, Global Product Head, Sanofi – Phase 3 IsKia trial of Sarclisa® (isatuximab)…

By. Terry Mamounas Date: 12/07/2023In a collaborative study between NVP and RT, led by oncologist…

By. Ash Alizadeh, MD Date: 12/13/2023 At ASH 2023, Dr. Ash Alizadeh, a distinguished medical…

By: Joyti Bajpai, MD Date: 12/07/2023 In a forthcoming interview, Jyoti Bajpai, MD, a renowned…

Catherine Diefenbach, MD, a Hematologist and Medical Oncologist at NYU Langone Health, led a study…